TSX open
Loading markets…

Advertisement

Stocks

Why MedMira Inc stock plummeted yesterday

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:MIR.V

Get MIR alerts:

Photos provided by Pexels

A sharp decline in MedMira Inc's stock raises concerns for investors.

MedMira Inc (MIR.V) experienced a significant drop in its stock price yesterday, closing down 14.29% at CA$0.06. This decline comes despite the company’s recent advancements in diagnostic technology and regulatory approvals.

Investor takeaway: Investors should be cautious as the recent drop in MedMira's stock price may reflect underlying challenges despite positive developments in product innovation.

Advertisement

MedMira Inc

MIR.V

Full stock page →

MIR.V

MedMira Inc

Source:WealthAwesomeWealthAwesome
$0.01 (-14.29%)
120 day period
$0.06$0.07$0.07Jan 15May 6Aug 12

Advertisement

Market cap

$45.61M

52W high

$0.11

52W low

$0.05

1W change

+0.00%

Beta

0.76

Advertisement

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MIR's historical volatility

HistoricalForecast68%95%
C$0.02C$0.05C$0.09C$0.13C$0.16C$0.20TodayMar 12Jun 1Aug 12Sep 24Nov 7Dec 20

30-Day Vol

96.6%

Annualized

90-Day Vol

103.2%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.06

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.06C$0.04C$0.08
60 trading daysC$0.06C$0.04C$0.10
90 trading daysC$0.06C$0.03C$0.11

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

MedMira Inc's stock fell 14.29% yesterday

Advertisement

The market cap now stands at approximately CA$42 million, reflecting investor concerns.

Bull case

MedMira's recent patent approvals for its quantitative diagnostic system could set the stage for future growth in the healthcare sector. These advancements might help the company tap into new opportunities and expand its market presence.

Bear case

The stock's steep decline indicates that the market is skeptical about MedMira's ability to turn its innovations into profitable revenue streams. Investors may be worried that the company won't be able to capitalize on its recent achievements.

Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 13, 2026
Last Updated: August 13, 2026

Sponsored links

Advertisement